Ustekinumab 90 mg Every 2 Weeks for the Treatment of Inflammatory Bowel Disease

Clin Gastroenterol Hepatol. 2021 Jul;19(7):1502. doi: 10.1016/j.cgh.2020.08.002. Epub 2020 Nov 26.

Authors

Darragh Storan¹, Glen A Doherty¹, Garret Cullen¹

Affiliation

¹ Centre for Colorectal Disease, St. Vincent's University Hospital, Dublin, Ireland; School of Medicine, University College Dublin, Dublin, Ireland.

PMID: 33248074
DOI: 10.1016/j.cgh.2020.08.002

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Colitis*
Crohn Disease*
Humans
Inflammatory Bowel Diseases* / drug therapy
Ustekinumab

Substances

Ustekinumab